A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

Angelo Sambunaris; Anjana Bose; Carl P. Gommoll; Changzheng Chen; William M. Greenberg; David V. Sheehan

doi:10.1097/jcp.0000000000000060

A Phase III, Double-Blind, Placebo-Controlled, Flexible-Dose Study of Levomilnacipran Extended-Release in Patients With Major Depressive Disorder

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0000000000000060 ◽

2014 ◽

Vol 34 (1) ◽

pp. 47-56 ◽

Cited By ~ 43

Author(s):

Angelo Sambunaris ◽

Anjana Bose ◽

Carl P. Gommoll ◽

Changzheng Chen ◽

William M. Greenberg ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Phase Iii ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study ◽

Flexible Dose

Get full-text (via PubEx)

Erratum: A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder

Neuropsychopharmacology ◽

10.1038/npp.2016.181 ◽

2016 ◽

Vol 41 (12) ◽

pp. 2961-2961 ◽

Cited By ~ 4

Author(s):

Atul R Mahableshwarkar ◽

John Zajecka ◽

William Jacobson ◽

Yinzhong Chen ◽

Richard SE Keefe

Keyword(s):

Major Depressive Disorder ◽

Cognitive Function ◽

Depressive Disorder ◽

Major Depressive ◽

Double Blind ◽

Dose Study ◽

Flexible Dose

Get full-text (via PubEx)

Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan

Neuropsychiatric Disease and Treatment ◽

10.2147/ndt.s146428 ◽

2018 ◽

Vol Volume 14 ◽

pp. 1261-1272 ◽

Cited By ~ 2

Author(s):

Yoshinori Watanabe ◽

Yuko Asami ◽

Yoko Hirano ◽

Kazuhiko Kuribayashi ◽

Rio Itamura ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Extended Release ◽

Controlled Study ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Subgroup Analyses ◽

Post Hoc

Get full-text (via PubEx)

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/yic.0b013e3283542457 ◽

2012 ◽

Vol 27 (4) ◽

pp. 215-223 ◽

Cited By ~ 233

Author(s):

Cornelius Katona ◽

Thomas Hansen ◽

Christina Kurre Olsen

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Fixed Dose ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study

Get full-text (via PubEx)

Efficacy and safety of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, randomized, double-blind, flexible-dose study

Psychopharmacology ◽

10.1007/s00213-010-1822-y ◽

2010 ◽

Vol 213 (2-3) ◽

pp. 639-646 ◽

Cited By ~ 10

Author(s):

Jian-Jun Ou ◽

Guang-Lei Xun ◽

Ren-Rong Wu ◽

Le-Hua Li ◽

Mao-Sheng Fang ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Dose Study ◽

Flexible Dose

Get full-text (via PubEx)

A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder

International Clinical Psychopharmacology ◽

10.1097/01.yic.0000194377.88330.1d ◽

2006 ◽

Vol 21 (3) ◽

pp. 159-169 ◽

Cited By ~ 54

Author(s):

David S. Baldwin ◽

James A. Cooper ◽

Anna K.T. Huusom ◽

Ian Hindmarch

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Treatment Discontinuation ◽

Major Depressive ◽

Double Blind ◽

Parallel Group ◽

Dose Study ◽

Flexible Dose

Get full-text (via PubEx)

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder

Journal of Psychopharmacology ◽

10.1177/0269881108100254 ◽

2009 ◽

Vol 24 (4) ◽

pp. 521-529 ◽

Cited By ~ 31

Author(s):

K. Hewett ◽

W. Chrzanowski ◽

R. Jokinen ◽

R. Felgentreff ◽

RK Shrivastava ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Elderly Patients ◽

Extended Release ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Controlled Evaluation

Get full-text (via PubEx)

Selegiline Transdermal System for the Treatment of Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Trial

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70775-8 ◽

2008 ◽

Vol 2008 ◽

pp. 197-198

Author(s):

J.C. Ballenger

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Dose Titration ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Flexible Dose

Get full-text (via PubEx)

A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2011.11.008 ◽

2012 ◽

Vol 22 (7) ◽

pp. 482-491 ◽

Cited By ~ 91

Author(s):

David S. Baldwin ◽

Henrik Loft ◽

Marianne Dragheim

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Acute Treatment ◽

Fixed Dose ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study

Get full-text (via PubEx)

Faculty Opinions recommendation of Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103835.559964 ◽

2008 ◽

Author(s):

Deborah Kim

Keyword(s):

Fatty Acids ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Trial ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Get full-text (via PubEx)

Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2021.1950437 ◽

2021 ◽

pp. 1-1

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Get full-text (via PubEx)